Skip to main content
Clinical Trials/ACTRN12622000838718
ACTRN12622000838718Not yet recruiting未知

The Efficacy of Microvascular Decompression for Unilateral Pulsatile Tinnitus- A Prospective Randomised Multicenter Study

Monash Health0 sites30 target enrollmentStarted: June 15, 2022Last updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
30

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to 75 Years (—)
Sex
All

Inclusion Criteria

  • The inclusion criteria are as follows: 1) age 18-75 years; 2) unilateral pulsatile tinnitus with some preservation of ipsilateral hearing; 3) MRI brain with no alternative major abnormality accounting for symptoms and there is identifiable vascular compression of the vestibulocochlear nerve; 4) all conservative therapies have been trialled and exhausted without significant symptom relief; 5) pre-op assessment by audiometry, vestibular testing and assessment by either a consultant ENT surgeon or Neurosurgeon who deem that microvascular decompression (MVD) is indicated; 6) patients with an American Society of Anaesthiology (ASA) score of I/II; and 7) patients have suffered from pulsatile tinnitus for >12 months

Exclusion Criteria

  • The exclusion criteria are as follows: 1) non-pulsatile tinnitus; 2) bilateral tinnitus; 3) abnormal MRI brain with significant structural abnormality; 4) previous retrosigmoid craniotomy or radiotherapy to the posterior fossa of the brain; 5) severe medical co-morbidities with ASA score III/IV; 6) patients with psychiatric comorbidity; 7) total deafness; and 8) inability to consent.

Investigators

Similar Trials